Cencora, Inc. (NYSE: COR) Company Profile

Background

Overview

Cencora, Inc., formerly known as AmerisourceBergen Corporation, is a leading global pharmaceutical sourcing and distribution services company. Established in 1871 and headquartered in Conshohocken, Pennsylvania, Cencora operates across the United States and internationally, providing a comprehensive range of services to healthcare providers, pharmaceutical manufacturers, and animal health companies.

Mission and Vision

Cencora's mission is to improve the health and well-being of people worldwide by delivering innovative and efficient pharmaceutical solutions. The company's vision is to be the most trusted partner in the healthcare industry, driving positive change through collaboration and excellence.

Primary Area of Focus

Cencora specializes in the sourcing and distribution of pharmaceutical products, including generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and related services. The company also offers specialty pharmaceutical products, vaccines, and animal health products.

Industry Significance

As a major player in the pharmaceutical distribution sector, Cencora plays a critical role in ensuring the efficient delivery of medications and healthcare products to a vast network of healthcare providers, thereby supporting the overall healthcare infrastructure.

Key Strategic Focus

Core Objectives

Operational Excellence: Enhancing supply chain efficiency to ensure timely and reliable delivery of pharmaceutical products.

Customer-Centric Services: Providing tailored solutions to meet the diverse needs of healthcare providers and pharmaceutical manufacturers.

Global Expansion: Strengthening international operations to expand market reach and service capabilities.

Specific Areas of Specialization

Pharmaceutical Distribution: Supplying a wide range of pharmaceutical products to various healthcare settings.

Animal Health Products: Offering pharmaceuticals, vaccines, and other products for companion and production animals.

Healthcare Services: Providing pharmacy management, staffing, consulting services, and data analytics.

Key Technologies Utilized

Supply Chain Management Systems: Advanced software solutions for inventory management and logistics optimization.

Data Analytics Platforms: Tools for analyzing market trends, customer behavior, and operational performance.

Clinical Trial Support Technologies: Systems that assist in the management and execution of clinical trials.

Primary Markets Targeted

Healthcare Providers: Hospitals, clinics, and pharmacies requiring reliable pharmaceutical supplies.

Pharmaceutical Manufacturers: Companies seeking distribution channels for their products.

Animal Health Sector: Veterinarians and animal health companies needing specialized products.

Financials and Funding

Funding History

Cencora, Inc. is a publicly traded company listed on the New York Stock Exchange under the ticker symbol "COR." As a publicly held entity, it has raised capital through the issuance of shares to the public and institutional investors.

Recent Financial Performance

As of April 10, 2026, Cencora's stock performance is as follows:

Stock Market Information for Cencora Inc. (COR)

Cencora Inc. is an equity in the USA market.

The price is 320.82 USD currently with a change of -1.56 USD (-0.00%) from the previous close.

The latest open price was 321.16 USD and the intraday volume is 1,028,767.

The intraday high is 322.76 USD and the intraday low is 314.79 USD.

The latest trade time is Friday, April 10, 16:15:00 PDT.

Utilization of Capital

The capital raised through public offerings is utilized for various strategic initiatives, including:

Acquisitions: Expanding service offerings and market presence.

Technology Investments: Enhancing digital infrastructure and data analytics capabilities.

Operational Expansion: Building new distribution centers and expanding logistics networks.

Pipeline Development

Key Pipeline Candidates

Cencora's pipeline primarily focuses on:

Pharmaceutical Products: Introducing new generic and specialty drugs to the market.

Animal Health Products: Developing innovative vaccines and treatments for animals.

Stages of Development

The company is involved in various stages of product development, from research and formulation to distribution and post-market support.

Target Conditions

Cencora's product development targets a wide range of medical conditions, including chronic diseases, infectious diseases, and conditions requiring specialized animal care.

Anticipated Milestones

Regulatory Approvals: Achieving necessary certifications and approvals for new products.

Market Launches: Introducing new products to the market in alignment with strategic goals.

Technological Platform and Innovation

Proprietary Technologies

Supply Chain Optimization Tools: Custom-developed software for efficient inventory and logistics management.

Data Analytics Platforms: In-house developed systems for analyzing market data and operational metrics.

Significant Scientific Methods

Clinical Trial Support Services: Utilizing advanced methodologies to support clinical trials, including data management and regulatory compliance.

Market Research Techniques: Employing sophisticated analytics to understand market dynamics and customer needs.

Leadership Team

Key Executives

Dr. Robert P. Mauch, Ph.D., PharmD: President, Chief Executive Officer, and Director. Dr. Mauch has extensive experience in the pharmaceutical industry, having held various leadership roles prior to joining Cencora.

James F. Cleary Jr.: Executive Vice President and Chief Financial Officer. Mr. Cleary brings a wealth of financial expertise, overseeing the company's financial operations.

Elizabeth S. Campbell, J.D.: Executive Vice President and Chief Legal Officer. Ms. Campbell provides strategic legal guidance, ensuring compliance and managing legal affairs.

Silvana Battaglia: Executive Vice President and Chief Human Resources Officer. Ms. Battaglia leads human resources, focusing on talent management and organizational development.

Lazarus Krikorian: Senior Vice President, Chief Accounting Officer, and Corporate Controller. Mr. Krikorian manages accounting functions and financial reporting.

Pawan Singh Verma: Executive Vice President and Chief Data and Information Officer. Mr. Verma oversees data strategy and information technology initiatives.

Bennett S. Murphy: Senior Vice President of Investor Relations and Enterprise Productivity and Treasury. Mr. Murphy manages investor relations and financial strategy.

Richard Tremonte: Executive Vice President and President of U.S. Pharmaceuticals and Animal Health. Mr. Tremonte leads U.S. pharmaceutical and animal health operations.

Juan Guerra: Executive Vice President and President of International Business Group. Mr. Guerra oversees international business development and operations.

François Mandeville: Executive Vice President and Chief Strategy and M&A Officer. Mr. Mandeville drives strategic initiatives and mergers and acquisitions.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical distribution industry is characterized by a large number of players, with several major companies dominating the market. The industry is experiencing growth due to increasing global healthcare needs, an aging population, and advancements in medical treatments.

Competitor Analysis

Cardinal Health (NYSE: CAH): A leading healthcare services and products company, Cardinal Health offers a broad range of pharmaceutical and medical products.

McKesson Corporation (NYSE: MCK): A global leader in healthcare supply chain management solutions, McKesson provides pharmaceuticals and medical supplies.

Henry Schein, Inc. (NASDAQ: HSIC): A provider of healthcare products and services to office-based dental and medical practitioners.

Strategic Collaborations and Partnerships

Cencora has established various partnerships with pharmaceutical manufacturers, healthcare providers, and technology companies to enhance its service offerings and expand its market reach.

Operational Insights

Cencora's extensive distribution network, advanced supply chain management systems, and comprehensive service portfolio provide a competitive edge in the pharmaceutical distribution sector.

Strategic Opportunities and Future Directions

Cencora is focusing on expanding its international presence, investing in digital transformation initiatives, and exploring strategic acquisitions to strengthen its market position and drive future growth.